A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis
Clinical trial NCT04781543 · TERMINATED
Trial details
- NCT number
- NCT04781543
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2025-02-24
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.